Allogene (ALLO) 2025 Earnings: Milestones and Outlook
As allogene (allo) 2025 earnings loom, investors weigh pipeline progress, collaboration milestones, and cash runway. ...
Which index type is best for passive investing? This guide compares index types, costs, and tracking performance to help you pick the most efficient option.
23,556 articlesAs allogene (allo) 2025 earnings loom, investors weigh pipeline progress, collaboration milestones, and cash runway. ...
In a volatile start to 2026, investors are seeking dividend ETFs built survive strategies that combine durable income...
General Mills faces a turning point in 2026. This in-depth look examines earnings drivers, margins, and cash returns,...
When a trusted income vehicle slumps by half, the question isn’t just about yield—it’s about safety, value, and the b...
Lumentum’s stock surged 1,000% over the past year as AI-driven demand for high-power lasers accelerates. A BNP Pariba...
Planet Labs delivered its first full year of profitability, with a ballooning backlog and AI partnerships driving a r...
AFC Gamma investors are watching the Q1 2026 earnings call closely. This guide breaks down what to expect, how to rea...
Berkshire Hathaway names Greg Abel as CEO, with Buffett signaling strong confidence as the company holds a cash-heavy...
As Turning Point Brands rode a wave of rising oral nicotine sales, one fund made a bold move: trimming a multi-millio...
Greg Abel is quietly rebalancing Berkshire Hathaway’s equity book, moving away from U.S. financials and toward intern...
Teva has climbed more than 100% in the last year, and analysts remain cautiously optimistic. Here’s why wall street t...
Vuzix is aiming to turn AR glasses into practical frontline tools. This guide breaks down what vuzix (vuzi) 2026 earn...